An important realization was that it’s not the primary tumor that often claims lives — it’s the spread of cancer to other ...

The researchers found that by blocking TXA2 production through aspirin or other cyclooxygenase-1 inhibitors, the immune system was better able to fight off metastatic cancer cells, reducing the ...

"It was a ‘eureka’ moment when we found TXA2 was the molecular signal that ... "This new study further demonstrates how aspirin and other inhibitors of this pathway could be used in new ...

The team found that ARHGEF1 is switched on when T cells are exposed to a clotting factor called thromboxane A2 (TXA2). TXA2 is produced by platelets in the blood and aspirin is already known to ...

Researchers found that aspirin decreases thromboxane A2 (TXA2) production, thus preventing T cell suppression and reducing the frequency of metastases in mice models. This discovery suggests a ...

The study, published in Nature, found that, in mice, aspirin acted on platelets — the tiny cells that cause blood to clot — making them produce less of a clotting factor, thromboxane A2 (TXA2 ...

A new study found that aspirin may help prevent some cancers from spreading by enhancing the immune system's ability to attack metastatic cells.

Too much of TXA2 can increase the risk of heart attacks ... "This new study further demonstrates how aspirin and other inhibitors of this pathway could be used in new treatments to prevent the ...